Rivastigmine as an alternative treatment for anticholinergic toxidrome in light of the physostigmine shortage: A case series
Our study shows that rivastigmine is a reasonable alternative to physostigmine based on the lack of adverse events reported and symptom relief.
Authors
- Adis Keric (ORCID: https://orcid.org/0000-0001-8348-0422)
- Jonathan Wilkinson (ORCID: https://orcid.org/0000-0001-6175-4576)
- Maarten P. van den Berg (ORCID: https://orcid.org/0000-0002-1493-2998)
- Neil Garrett (ORCID: https://orcid.org/0000-0003-1440-472X)
- Annika Strand
Institutions
- Regions Hospital (US)
Publication Details
- Journal
- The American Journal of Emergency Medicine
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1016/j.ajem.2025.04.047
- Citations
- 4
- Primary Topic
- Poisoning and overdose treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.01